KEGG   DRUG: D08985Help
Entry
D08985                      Drug                                   

Name
Reslizumab (USAN)
Activity
Treatment of bronchial asthma as well as a pharmacological tool to elucidate the role of IL-5 in human eosinophilic diseases
Comment
Monoclonal antibody
Target
interleukin 5 (IL-5) [HSA:3567] [KO:K05428]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  Jak-STAT signaling pathway  
 
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines
  Class I cytokines
   IL-5
    Reslizumab
     D08985  Reslizumab (USAN)
BRITE hierarchy
Other DBs
CAS: 
241473-69-8
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system